Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...

The stock's rise snapped a three-day losing streak.

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ ...

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports.

Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, March 11th. William ...

HSIC shares have lagged the broader market over the past year, rising just 2.9% compared to the S&P 500 Index 20.7% surge.However, in 2025, the stock has gained momentum, climbing 11.6% year-to ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

While Henry Schein has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question ...

HENRY SCHEIN ($HSIC) posted quarterly earnings results on Tuesday, February 25th. The company reported earnings of $1.19 per share, missing estimates of $1.24 by $0. ...